A novel canine model for prostate cancer

Prostate

Volumn 73, Issue 9, 2013, Pages 952-959

  Keller, Jill M ^a   Schade, George R ^a   Ives, Kimberly ^a   Cheng, Xu ^a   Rosol, Thomas J ^b   Piert, Morand ^c   Siddiqui, Javed ^a   Roberts, William W ^a   Keller, Evan T ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

animal model; dog; metastasis; prostate cancer

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; CANCER CELL CULTURE; DOG; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; MALE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSTATE CANCER; TRANSRECTAL ULTRASONOGRAPHY; TUMOR CELL;

ANIMALS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; DOGS; MALE; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; NEOPLASTIC CELLS, CIRCULATING; POSITRON-EMISSION TOMOGRAPHY; PROSTATIC NEOPLASMS;

EID: 84878268414     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22642     Document Type: Article

References (26)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D,. Global cancer statistics. CA Cancer J Clin 2011; 61 (2): 69-90.
2. Wang F,. Modeling human prostate cancer in genetically engineered mice. Prog Mol Biol Transl Sci 2011; 100: 1-49.
3. Hensley PJ, Kyprianou N,. Modeling prostate cancer in mice: Limitations and opportunities. J Androl 2012; 33 (2): 133-144.
4. Leroy BE, Northrup N,. Prostate cancer in dogs: Comparative and clinical aspects. Vet J 2009; 180 (2): 149-162.
5. Coffey DS, Walsh PC,. Clinical and experimental studies of benign prostatic hyperplasia. Urol Clin North Am 1990; 17 (3): 461-475.
6. Waters DJ, Bostwick DG,. The canine prostate is a spontaneous model of intraepithelial neoplasia and prostate cancer progression. Anticancer Res 1997; 17 (3A): 1467-1470.
7. Rosol TJ, Tannehill-Gregg SH, LeRoy BE, Mandl S, Contag CH,. Animal models of bone metastasis. Cancer 2003; 97 (3 Suppl): 748-757.
8. LeRoy BE, Thudi NK, Nadella MV, Toribio RE, Tannehill-Gregg SH, van Bokhoven A, Davis D, Corn S, Rosol TJ,. New bone formation and osteolysis by a metastatic, highly invasive canine prostate carcinoma xenograft. Prostate 2006; 66 (11): 1213-1222.
9. Thudi NK, Martin CK, Murahari S, Shu ST, Lanigan LG, Werbeck JL, Keller ET, McCauley LK, Pinzone JJ, Rosol TJ,. Dickkopf-1 (DKK-1) stimulated prostate cancer growth and metastasis and inhibited bone formation in osteoblastic bone metastases. Prostate 2011; 71 (6): 615-625.
10. Thudi NK, Martin CK, Nadella MV, Fernandez SA, Werbeck JL, Pinzone JJ, Rosol TJ,. Zoledronic acid decreased osteolysis but not bone metastasis in a nude mouse model of canine prostate cancer with mixed bone lesions. Prostate 2008; 68 (10): 1116-1125.
11. Pienta KJ, Abate-Shen C, Agus DB, Attar RM, Chung LW, Greenberg NM, Hahn WC, Isaacs JT, Navone NM, Peehl DM, Simons JW, Solit DB, Soule HR, VanDyke TA, Weber MJ, Wu L, Vessella RL,. The current state of preclinical prostate cancer animal models. Prostate 2008; 68 (6): 629-639.
12. Russell PJ, Voeks DJ,. Animal models of prostate cancer. Methods Mol Med 2003; 81: 89-112.
13. Mahapokai W, Van Sluijs FJ, Schalken JA,. Models for studying benign prostatic hyperplasia. Prostate Cancer Prostatic Dis 2000; 3 (1): 28-33.
14. Madewell BR, Gandour-Edwards R, DeVere White RW,. Canine prostatic intraepithelial neoplasia: Is the comparative model relevant? Prostate 2004; 58 (3): 314-317.
15. Pollard M, Suckow MA,. Hormone-refractory prostate cancer in the Lobund-Wistar rat. Exp Biol Med (Maywood) 2005; 230 (8): 520-526.
16. Pollard M,. The Lobund-Wistar rat model of prostate cancer. J Cell Biochem Suppl 1992; 16H: 84-88.
17. Blouin S, Basle MF, Chappard D,. Rat models of bone metastases. Clin Exp Metastasis 2005; 22 (8): 605-614.
18. Evans HE,. Miller's anatomy of the dog, 3rd edition. Philadelphia: W.B. Saunders; 1993.
19. Park SI, McCauley LK,. Nuclear localization of parathyroid hormone-related peptide confers resistance to anoikis in prostate cancer cells. Endocr Relat Cancer 2012; 19 (3): 243-254.
20. Podgorski I, Linebaugh BE, Sloane BF,. Cathepsin K in the bone microenvironment: Link between obesity and prostate cancer? Biochem Soc Trans 2007; 35 (Pt 4): 701-703.
21. Thompson EW, Newgreen DF, Tarin D,. Carcinoma invasion and metastasis: A role for epithelial-mesenchymal transition? Cancer Res 2005; 65 (14): 5991-5995; discussion 5995.
22. Avila DM, Zoppi S, McPhaul MJ,. The androgen receptor (AR) in syndromes of androgen insensitivity and in prostate cancer. J Steroid Biochem Mol Biol 2001; 76 (1-5): 135-142.
23. Teske E, Naan EC, van Dijk EM, Van Garderen E, Schalken JA,. Canine prostate carcinoma: Epidemiological evidence of an increased risk in castrated dogs. Mol Cell Endocrinol 2002; 197 (1-2): 251-255.
24. Argyle DJ,. Prostate cancer in dogs and men: A unique opportunity to study the disease. Vet J 2009; 180 (2): 137-138.
25. Fork MA, Murua Escobar H, Soller JT, Sterenczak KA, Willenbrock S, Winkler S, Dorsch M, Reimann-Berg N, Hedrich HJ, Bullerdiek J, Nolte I,. Establishing an in vivo model of canine prostate carcinoma using the new cell line CT1258. BMC Cancer 2008; 8: 240.
26. Anidjar M, Scarlata E, Cury FL, Rocha J, Hamel L, Luz M, Chevalier S,. Refining the orthotopic dog prostate cancer (DPC)-1 model to better bridge the gap between rodents and men. Prostate 2012; 72 (7): 752-761.